Research programme: oral insulin analogues - Novo Nordisk
Latest Information Update: 16 Jul 2016
At a glance
- Originator Novo Nordisk
- Class Insulins
- Mechanism of Action Insulin receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Diabetes mellitus
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Diabetes-mellitus in Denmark (PO)
- 22 Dec 2010 Early research in Diabetes mellitus in Denmark (PO)